Small Animal Medicine & Surgery, Oncology Service, Veterinary Teaching Hospital

Clinical Associate Professor

Biography

Education

  • Residency, Medical Oncology, Flint Animal Cancer Center, Colorado State University
  • Rotating Internship, Veterinary Specialty Hospital of the Carolinas
  • V.M.D., University of Pennsylvania, 2012
  • Ph.D., Cell Biology, University of Alabama at Birmingham, 2008
  • B.S., Biochemistry and Molecular Biology, Mississippi State University, 2002

Professional Certifications

Diplomate American College of Veterinary Internal Medicine (Oncology), 2017

Teaching Experience

SAMS 5302 – Small animal oncology

SAMS 5350 – Small animal digestive diseases

VETM 5150 – Applied Integrative Material II and III (AIMS II and III)

Research Interests

  • Comparative oncology
  • Molecular oncology
  • Proteasome inhibition
  • NF-kappaB signaling

Publications

  • Lee BM, Clarke D, Watson M, Laver T: Retrospective evaluation of a modified human lung cancer stage classification in dogs with surgically excised primary pulmonary carcinomas. Veterinary and Comparative Oncology, 18(4):590-598. 2020. doi: org/10.1111/vco.12582
  • Grimes JA, Secrest SA, Wallace ML, Laver T, Schmiedt CW: Use of Indirect computed tomography lymphangiography to determine metastatic status of sentinel lymph nodes in dogs with a pre-operative diagnosis of melanoma or mast cell tumor. Veterinary and Comparative Oncology, 18(4):818-824. 2020. org/10.1111/vco.12592
  • Laver T, Feldhaeusser BR, Robat CS, Baez JL, Cronin KL, Buracco P… Thamm DH: Post-surgical outcome and prognostic factors in canine malignant melanomas of the haired skin: 87 cases (2003-2015). Canadian Veterinary Journal, 59(9):981-987. 2018
  • LaverT, London CA, Vail DM, Biller BJ, Coy J, Thamm DH: Prospective Evaluation of Toceranib Phosphate in Metastatic Canine Osteosarcoma. Veterinary and Comparative Oncology, 16(1):E23-29. 2017. doi:org/10.1111/vco.12328
  • Zhao X, Laver T, Hong SW, Twitty GB, DeVos A, DeVos M, . . . Nozell SE: An NF-κB p65-cIAP2 Link is Necessary for Mediating Resistance to TNF-α Induced Cell Death in Gliomas. Journal of Neuro-Oncology, 102(3), 367-381. 2011. doi:1007/s11060-010-0346-y
  • Nozell S, Laver T, Moseley D, Nowoslawski L, DeVos M, Atkinson GP, . . . Benveniste EN: The ING4 Tumor Suppressor Attenuates NF-†B Activity at the Promoters of Target Genes. Molecular and Cellular Biology, 28(21), 6632-6645. 2008. doi:1128/MCB.00697-08
  • Laver T, Nozell SE, & Benveniste EN: IFN- β -Mediated Inhibition of IL-8 Expression Requires the ISGF3 Components Stat1, Stat2, and IRF-9. Journal of Interferon & Cytokine Research, 28(1), 13-23. 2008. doi:1089/jir.2007.0062

going beyond the expected